AZoNano.com

RUSNANOPRIZE Award 2013 for Achievements in Nanomaterials and Surface ... AZoNano.com Professor Lukyanov also had a successful business in the field of molecular genetics, and a score of 40 in the Hirsch Index at the same time. Anatoly Chubays, the RUSNANO CEO, presents the RUSNANOPRIZE Award to Prof. Sergey Lukyanov at the 2012 ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFqopuDRiQ2dFMunyGxc14X2sgY6w&url=http://www.azonano.com/article.aspx?ArticleID%3D3536

Ami Ahern-Rindell Brings 20 Years of Experience to Undergraduate Research ... Newswise (press release) She earned her M.S. and Ph.D. degrees in Genetics and Cell Biology from Washington State University and was an NIH Postdoctoral Fellow at the Center for Molecular Genetics at the University of California, San Diego. In 1992, she received her first ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHiyaykpJjxzw0V5jyd8vQRQ_kMuA&url=http://www.newswise.com/articles/council-on-undergraduate-research-elects-new-president2?ret%3D/articles/list%26category%3Dlife%26page%3D1%26search%255Bstatus%255D%3D3%26search%255Bsort%255D%3Ddate%2Bdesc%26search%255Bsection%255D%3D30%26search%255Bhas_multimedia%255D%3D

“One eventual obstacle, even if tests
go well, could be cost: (Masayuki) Yamato (of Tokyo Women's Medical
University) says initial estimates for the treatment run around ¥50
million ($512,000) per person."

“The cost impact of the therapy is
likely to be high, because of a therapy’s high cost per patient,
and the potentially large number of individuals who might benefit
from the therapy. This expense would put additional stress on
the Medicare and Medicaid budgets, cause private
insurance health premiums to increase, and create an incentive for
private plans to avoid covering individuals eligible for a therapy.”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/IObtHBtAe_E/cost-of-stem-cell-therapy-estimated.html

“Shares of the Cambridge life
sciences company bluebird bio Inc. soared almost 60 percent on their
first day of trading (last) Wednesday, an impressive debut for a
business that endured years of stagnation and another encouraging
sign for the biotechnology industry.

“The local gene therapy company
raised $101 million in an initial public offering priced at $17 per
share, higher than the $14 to $16 estimated by investment bankers.
Bluebird shares closed at $26.91 per share on Wednesday.”

“Bluebird Bio, one of the oldest
companies in the struggling gene therapy field, is having an
outstanding first day in the stock market today, and largely by
marrying its gene therapy technology with stem cell science. The
company’s financial milestone brings hope and excitement to both
fields.”

“One of the main goals of
California’s $3 billion stem cell research agency is to draw
companies into the state so they can vie for a share of the funding.

"With a recently funded $32 million
initiative, the California
Institute for Regenerative Medicine(CIRM) has attracted two of
the biggest US players in stem cell banking to Novato, CA, to form
one of the largest biobanks of induced pluripotent stem cells (iPS
cells) in the world.”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/6WeU6kIIs6E/bluebird-and-banking-media-pluses-for.html

MANILA - As stem cell treatment begins to gain traction among Filipinos, a surgeon believes the country is now entering a new phase in medicine.

Dr. Levi John Lansangan, one of the founding members of the Philippine Stem Cell Society, said there is much promise in stem cell therapy because of the hope it gives to ailing patients.

"Before it was only physiologic, then it became pathologic, which deals with diseases. Then it became pharmacologic, wherein we give medicine. But now it is regenerative, wherein the body heals by itself," Lansangan told ANC's "Prime Time" on Wednesday.

Stem cell treatment involves harvesting stem cells, processing them, and injecting them back to the body.

Lansangan said the autologous treatment, which harvests stem cells from the patients own system, is the safest type of stem cell procedure.

The procedure may last for up to 4 hours, depending on the patients health. It may cost up to P1.6 million.

Stem cell treatment is believed to have the potential to cure illnesses including diabetes, heart ailments, brain damage such as Parkinsons and Alzheimers, osteoarthritis, stroke, baldness and even sports injuries.

The hardest thing to say to a patient is hopelessness. If you say there is no hope for the disease, it is very unacceptable for the patient. But with stem cell, were giving hope. Not hope in the sense that we are just giving placebo but hope that there is really something into it thats really big, Lansangan said.

But Lansangan warned that there are also risks involved in the process, particularly if stem cells are derived from animals such as rabbits and black sheep.

There are a lot of sources for stem cell. But the only stem cell sources approved by the DOH [Department of Health] come from the bone marrow, fats and blood of the patient itself. We dont recognize xenograph, or from animals. That is where the problem lies, he said.

Continue reading here:
Giving hope: The promise of stem cell therapy

Stem Cell Therapy Clinics - Regenerative Medicine with Research Studies
http://r3stemcell.com R3 Stem Cell Clinics offer stem cell injection treatments, such as platelet rich plasma therapy, bone marrow derived stem cells and amn...

By: USPainNetwork

See the original post:
Stem Cell Therapy Clinics - Regenerative Medicine with Research Studies - Video

Rylee May Post Stem Cell Therapy
This was taken about 7-8 months after stem cell therapy. We have a great improvement in the ability to walk without pain from hip dysplasia.

By: Tim O #39;Neill, DVM

View original post here:
Rylee May Post Stem Cell Therapy - Video

kgw.com

Genetic engineering and the alien wheat in Oregon Los Angeles Times There's a dearth of evidence that genetically engineered food is dangerous to human health — but that doesn't mean consumers are wrong to have concerns about its effect on the environment and on non-bioengineered crops. U.S. agribusiness has rushed ... Guest opinion: Farmers will keep adaptingThe Spokesman Review GM wheat success hinges on end to zero toleranceWestern Producer (subscription) Wheat industry will survive Oregon's genetically engineered strainWalla Walla Union-Bulletin all 106 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEOv7rjgzxuZlHV-HX8jHTouQ1smQ&url=http://www.latimes.com/news/opinion/opinion-la/la-ol-gmo-wheat-oregon-20130617,0,7467746.story

Art forgery meets genetic engineering in ' A Nearly Perfect Copy ' STLtoday.com Allison Amend's debut novel, “Stations West,” was a fascinating historical portrait of Jews trying to survive in the American Southwest. Her second novel binds together a metaphorical story of human genetic engineering and art forgery. Though the book ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHDsoXw1U8iVyNsPTEBUEAkvNfI7Q&url=http://www.stltoday.com/entertainment/books-and-literature/reviews/art-forgery-meets-genetic-engineering-in-a-nearly-perfect-copy/article_4e8b7736-8a0d-50af-9e31-bc6f1a5e1712.html

Reason

World Food Prize shared by Syngenta Biotechnology founder Durham Herald Sun In 1983, she was recruited to the business that would become Syngenta Biotechnology. The Research Triangle Park-based subsidiary of the Swiss agribusiness company now works to develop genetic traits for crops in order to boost yield, to increase ... Three Biotechnology Scientists Awarded 2013 World Food PrizeAgWeb Monsanto Crop Biotechnology Reseacher is Among World Food Prize LaureatesReason Biotechnology experts win food prizeSan Francisco Chronicle Reuters -Washington University in St. Louis News all 88 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEvxTFLuRftLP_LY9RmLIwmw8k-zg&url=http://www.heraldsun.com/news/x265262184/Syngenta-Biotechnology-founder-honored

Spy who came in from the cold sees future in biotechnology Financial Times Anna Chapman: Since the beginning of the 21st century there has been a revolution in biotechnology. In 2000 the first artificial organ was created (urinary bladder). In 2003, the human genome was decoded. In 2007, scientists managed to prolong the life ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNG13d5OewlgSpxqarBW84vMYSJp6Q&url=http://www.ft.com/cms/s/0/1d3dace2-cf62-11e2-a050-00144feab7de.html

CRT Capital Hires Arlinda Lee, Ph.D. as Lead Biotechnology Analyst EON: Enhanced Online News (press release) BUSINESS WIRE)--CRT Capital Group LLC ("CRT"), an independent institutional broker-dealer based in Stamford, Connecticut, today announced that Arlinda Lee, Ph.D. has joined its highly regarded Health Care Research team as Lead Biotechnology ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFZBMWF_eHKDGdGP8J_-aLza-MsmA&url=http://eon.businesswire.com/news/eon/20130621005063/en/crt-capital/broker-dealer

Plandaí Biotechnology, Inc. Announces Favorable Anti-Malaria Test Results In ... MarketWatch SEATTLE, WA--June 20, 2013--Plandaí Biotechnology, Inc. (otcqb:PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced the results of further in vitro testing ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHi1oBsFfM2Gf25l5iPQR3vK_4k6Q&url=http://www.marketwatch.com/story/planda%25C3%25AD-biotechnology-inc-announces-favorable-anti-malaria-test-results-in-second-round-of-in-vitro-testing-2013-06-20?reflink%3DMW_news_stmp

Agriculture.com

Researchers named 2013 WFP Laureates Agriculture.com It also marks the 60th anniversary of the discovery of the DNA double-helix structure, one critical to the advancement of what would become today's study of molecular genetics and the continued development of biotechnology that raises crop yields and ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGs0T8aR8h_uL7voxoy_uGlmYzZfQ&url=http://www.agriculture.com/news/business/researchers-named-2013-wfp-laureates_5-ar32074

Monsanto's Robert T. Fraley Named 2013 World Food Prize Laureate GardenNews.biz (press release) "During the last 60 years, the science of molecular genetics, also referred to as New Genetics, has opened up uncommon opportunities for shaping the future of agriculture, industry, medicine and environment protection," said Dr. M.S. Swaminathan ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEF_Y_Em7D5DvHORH3N0wiQ-Lv6vw&url=http://gardennews.biz/?id%3D11732

Richard Dawkins on the internet's hijacking of the word 'meme' Wired.co.uk In advance of this extraordinary performance, Wired.co.uk caught up with Dawkins to talk about his own favourite internet memes, Twitter, molecular genetics, false memories and, er..., Celebrity Big Brother. Wired.co.uk: How did you get involved in the ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEaeFk2Yt-0TS_7skG9k7H-6_2B9g&url=http://www.wired.co.uk/news/archive/2013-06/20/richard-dawkins-memes

UW Today

US Supreme Court decision to bar gene patents opens genetic test options UW Today According to Jonathan Tait, professor of laboratory medicine and director of the Clinical Molecular Genetics Laboratory at University of Washington Medical Center, “The Supreme Court decision is broadly beneficial to UW Medicine, going well beyond ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEevcbUD2nNAprCatZFk9pdfQyfNA&url=http://www.washington.edu/news/2013/06/20/u-s-supreme-court-decision-opens-genetic-test-options/

Indiana Public Media

New Indiana University trustees appointed by Gov. Mike Pence Indiana University She currently is studying medical and molecular genetics and is a member of the Medical Student Council at the School of Medicine. She has also served on IU's Board of Aeons, a 12-member student board that conducts research projects for the president's ... IU Board of Trustees Adds Student, Business LeadersIndiana Public Media Pence Names IU TrusteesInside INdiana Business (press release) all 9 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGgsYYLjzyzvjx8IbjBnmNl4Vmq4Q&url=http://newsinfo.iu.edu/news/page/normal/24354.html

ABC News

Three biotechnology scientists awarded 2013 World Food Prize agprofessional.com “During the last 60 years, the science of molecular genetics, also referred to as New Genetics, has opened up uncommon opportunities for shaping the future of agriculture, industry, medicine and environment protection. It is therefore appropriate that ... 2013 World Food Prize laureates announcedAgriLife Today Three Scientists Win US World Food PrizeRTT News all 88 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFJ7lD-ZNPQg4jMFzckpth0LPqqfQ&url=http://www.agprofessional.com/news/Three-biotechnology-scientists-awarded-2013-World-Food-Prize-212198721.html

On 18 June 2013, there was an announcement at the Princess Margaret Cancer Centre, Toronto. There was also a post on the California stem cell agency blog entitled: Clinical trial to thwart cancer stem cells may begin soon. An excerpt from the post:

The Prince Margaret Center announced the FDA filing, called an Investigational New Drug application (IND), at an event in Toronto recognizing the private donors. A press release about the announcement was picked up at this biotech news site.

The Principal Investigators present for the announcement were Dr. Tak Mak of the Princess Margaret Cancer Centre and Dr. Dennis Slamon of the University of California, Los Angeles (UCLA). What they have done is summarized in another excerpt from the blog post:

By working first to understand the various proteins that drive cells to divide, particularly in cancer, they were able to pinpoint an enzyme, that if blocked, could be the key to keeping cancer in check. They then discovered that this enzyme, called PLK4, can be derailed by a new drug they developed. In the lab, it has been shown to inhibit the growth of breast, ovarian, colorectal, lung, pancreatic and prostate cancer, as well as melanoma.

Information about the human PLK4 protein is available here.

Some background: In June 2008, it was announced that a partnership had been formed between Canada’s Cancer Stem Cell Consortium (CSCC) and the California Institute for Regenerative Medicine (CIRM) for international collaboration to advance cancer stem cell research. An excerpt from the CSCC's announcement:

It is proposed that one of the first initiatives to be launched by the CSCC will be a collaboration between Canadian and Californian scientists through CIRM's upcoming Disease Team Research Awards Competition, which will support multi-disciplinary teams of scientists in pursuit of therapies for specific diseases.The goal is to fund teams that will develop therapy or diagnostics for a particular disease or serious injury.Successful proposals will likely include a description of a path to an Investigational New Drug filing at the end of the four-to-five year grant.

Note the intent to file an IND by the end of the term of the grant.

The results of the Disease Team Research Awards Competition were announced on October 28, 2009. The award to Drs. Slamon and Mak is Grant number DR1-01477. See: Therapeutic Opportunities to Target Tumor Initiating Cells in Solid Tumors. As was stated in a page about Cancer Stem Cells on the website of the Canadian Institutes for Health Research (CIHR), this award was to one of two multi-disciplinary research teams co-led by Canadian and Californian scientists. The other team is co-led by Dr. John Dick of the University Health Network and Dr. Dennis Carson of the University of California, San Diego. My blog post (October 29, 2009) about the awards is entitled: Disease Team awards announced. The post ends with this Disclosure:

I'm a member of the Board of the CSCC, but also a staff member (emeritus) at the University Health Network. So, I was in conflict of interest, and was absent during all of the discussions, by the CSCC Board, about which Canadian applications should be considered for the Disease Team awards.

Source:
http://cancerstemcellnews.blogspot.com/2013/06/international-team-submits-ind.html